E-Paper
FDA okay's Glenmark's epilepsy drug
Glenmark Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration to sell zonisamide capsules.
Published on: Feb 3, 2006, 13:41:00 IST
Share via
Copy link
Indian drug maker Glenmark Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration to sell zonisamide capsules in 25 mg, 50 mg and 100 mg strengths in the United States.
Zonisamide is the generic version of Eisai Inc's Zonegran, used to treat epilepsy.
Follow India news real-time updates and the latest news covered on Hindustan Times, featuring today's critical updates on Sonam Wangchuk LIVE and more across India.
